Critical CareAKIbiomarkers
STARDaki: Standardizing How We Report Acute Kidney Injury Biomarker Studies
By MedXY|Jul 30, 2026
An expert consensus (STARDaki) extends STARD to improve reporting of diagnostic test accuracy studies for acute kidney injury (AKI), specifying patient selection, reference standards, timing, assay details and test-retest reliability.